Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
12.57
-0.07 (-0.55%)
At close: Dec 19, 2025, 4:00 PM EST
12.66
+0.09 (0.72%)
After-hours: Dec 19, 2025, 7:55 PM EST
Amneal Pharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$13.25
Upside
+5.41%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Initiates $15 | Buy | Initiates | $15 | +19.33% | Dec 9, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $11 → $13 | Buy | Reiterates | $11 → $13 | +3.42% | Oct 31, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +11.38% | Sep 16, 2025 |
| Barclays | Barclays | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | -12.49% | Mar 3, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $9 → $12 | Hold → Buy | Upgrades | $9 → $12 | -4.53% | Feb 24, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $11 | Buy | Maintains | $9 → $11 | -12.49% | Nov 11, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | -4.53% | Oct 2, 2024 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $9 | Sell → Hold | Upgrades | $9 | -28.40% | Sep 6, 2024 |
| Barclays | Barclays | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | -20.45% | Aug 13, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | -20.45% | Aug 12, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $6.25 → $8 | Strong Buy | Maintains | $6.25 → $8 | -36.36% | May 6, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $7 → $9 | Strong Buy | Reiterates | $7 → $9 | -28.40% | May 6, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | -36.36% | Mar 21, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $5.5 → $6.25 | Strong Buy | Maintains | $5.5 → $6.25 | -50.28% | Mar 4, 2024 |
| Barclays | Barclays | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | -36.36% | Jan 29, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | -44.31% | Nov 8, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.